T. Rowe Price Associates »

Nervgen Pharma Ord shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGEN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $59k 16k 3.81

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Nervgen Pharma Ord

Empery Asset Management
Rock Springs Capital Management
DAFNA Capital Management
Ghisallo Capital Management
Armistice Capital
LMR Partners
Marshall Wace
UBS Group
Stonepine Capital Management
Jane Street
Woodline Partners
PFG Investments
Susquehanna International
Bank of America Corporation
Royal Bank of Canada

View all funds holding Nervgen Pharma Ord